Camber launches generic Baraclude

PISCATAWAY, N.J. — Camber Pharmaceuticals last week announced its introduction of its entecavir tablet in 0.5- and 1-mg dosage strengths. The drug is a generic version of Bristol-Myers Squibb’s Baraclude, and the chronic hepatitis B treatment will be available from Camber in 30 and 90 count bottles of 0.5 mg strength tablets, and 30 count bottles of the 1-mg tablets.